PetMed Express, Inc. (PETS)
NASDAQ: PETS · Real-Time Price · USD
0.8995
+0.0018 (0.20%)
At close: Nov 17, 2026, 4:00 PM EST
0.9000
+0.0005 (0.06%)
After-hours: Nov 17, 2026, 7:06 PM EST
PetMed Express Revenue
PetMed Express had revenue of $35.77M in the quarter ending September 30, 2026, a decrease of -19.37%. This brings the company's total for the last twelve months to $160.26M, down -19.17% year-over-year. In the fiscal year ending March 31, 2026, PetMed Express had annual revenue of $179.02M, down -21.13%. That makes PetMed Express the 19,121st largest company in the world by revenue and 3,004th in the United States.
Revenue (ttm)
$160.26M
Revenue Growth
-19.17%
P/S Ratio
0.12
Revenue / Employee
$847,947
Employees
189
Market Cap
19.08M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 179.02M | -47.95M | -21.13% |
| Mar 31, 2025 | 226.97M | -47.12M | -17.19% |
| Mar 31, 2024 | 274.10M | 26.53M | 10.71% |
| Mar 31, 2023 | 247.57M | -24.71M | -9.08% |
| Mar 31, 2022 | 272.28M | -31.30M | -10.31% |
| Mar 31, 2021 | 303.58M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 450.06B |
| Johnson & Johnson | 99.34B |
| Eli Lilly and Company | 86.46B |
| AbbVie | 66.01B |
| P3 Health Partners | 1.55B |
| DocGo | 297.34M |
| Aytu BioPharma | 57.57M |
| BioStem Technologies | 31.75M |
PETS News
- 7 days ago - PetMed Express Earnings Call Transcript: Q2 2027 - Transcripts
- 7 days ago - PetMed Express Earnings release: Q2 2027 - Filings
- 7 days ago - PetMed Express Quarterly report: Q2 2027 - Filings
- 7 days ago - PetMeds® Announces Second Quarter Financial Results - GlobeNewsWire
- 8 days ago - PetMeds Announces Strategic Partnership with Pet Supermarket to Expand Pharmacy Offering Across Retail and Digital Channels - GlobeNewsWire
- 21 days ago - PetMed Express, Inc. to Report Second Quarter Fiscal Year 2027 Financial Results on Tuesday, November 10, 2026 - GlobeNewsWire
- 6 weeks ago - PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - PetMed Express price target lowered to $1.40 from $2.15 at Morgan Stanley - TheFly